Achaogen launches ZEMDRI™ (plazomicin), a once-daily Aminoglycoside for use in cUTI
Achaogen announced that ZEMDRI is now available for ordering. ZEMDRI is approved in the United States for the treatment of adults with cUTI, including pyelonephritis, due to certain Enterobacteriaceae. ZEMDRI was approved by the FDA on June 25, 2018. July 20, 2018